David Moatazedi's Net Worth
$17.1 Million
Who is David Moatazedi?
David Moatazedi has an estimated net worth of $17.1 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., OBALON THERAPEUTICS INC, and BIOMERICA INC.
SEC CIK
David Moatazedi's CIK is 0001700836
Past Insider Trading and Trends
2023 was David Moatazedi's most active year for acquiring shares with 7 total transactions. David Moatazedi's most active month to acquire stocks was the month of December. 2024 was David Moatazedi's most active year for disposing of shares, totalling 9 transactions. David Moatazedi's most active month to dispose stocks was the month of February. 2018 saw David Moatazedi paying a total of $8,605,098.32 for 1,345,567 shares, this is the most they've acquired in one year. In 2024 David Moatazedi cashed out on 929,209 shares for a total of $7,741,593.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evolus, Inc. (EOLS) Snapshot price: $14.71
See RemarksDavid Moatazedi owns 533,349 units of Common Stock which is worth $7,845,563.79. From 2018 to 2024 David Moatazedi acquired a total of 1,560,765 shares in Evolus, Inc. at a cost of $2,595,500.42, David also disposed a total of 985,653 shares of Evolus, Inc. equalling to $11,818,479.31.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.82% | -140.21K |
$9.59 | -$3,876,966.91 | 533.35K |
Jun 4 - Jun 6
| |||
Form 4
| -2.33% | -16.05K |
$12.72 | -$204,126.99 | 673.56K |
May 10
| |||
Form 4
| -0.90% | -6.24K |
$13.86 | -$86,430.96 | 689.61K |
Mar 27
| |||
Form 4
| -12.19% | -96.57K |
$13.92 | -$1,344,604.30 | 695.85K |
Mar 19
| |||
Form 4
| +7.24% | 53.5K |
$13.08 | -$100,803.73 | 792.42K |
Scheduled
|
Feb 21 - Feb 22
| ||
Form 4
| +22.35% | 134.98K |
—
|
—
| 738.92K |
Feb 7
| |||
Form 4
| -12.04% | -82.65K |
$9.95 | -$822,395.97 | 603.94K |
Dec 6 - Dec 8
| |||
Form 4
| +12.64% | 77.03K |
$10.27 | -$151,770.06 | 686.59K |
Aug 14 - Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| -0.99% | -6.11K |
$8.47 | -$51,751.70 | 609.57K |
Mar 27
| |||
Form 4
| -9.44% | -64.21K |
$8.47 | -$543,796.54 | 615.68K |
Scheduled
|
Mar 14
| ||
Form 4
| +38.20% | 187.93K |
—
|
—
| 679.89K |
Jan 25
| |||
Form 4
| -10.11% | -55.32K |
$13.64 | -$754,307.37 | 491.96K |
May 16
| |||
Form 4
| -1.10% | -6.10K |
$11.62 | -$70,928.48 | 547.28K |
Scheduled
|
Mar 28
| ||
Form 4
| -6.42% | -37.97K |
$9.73 | -$369,292.89 | 553.39K |
Scheduled
|
Mar 8
| ||
Form 4
| +56.83% | 214.29K |
—
|
—
| 591.36K |
Jan 24
| |||
Form 4
| -15.74% | -70.44K |
$11.13 | -$783,810.39 | 377.07K |
Aug 13 - Aug 16
| |||
Form 4/A
| -8.54% | -41.76K |
$11.18 | -$466,839.34 | 447.52K |
Scheduled
|
Aug 10
| ||
Form 4
| +8.54% | 41.76K |
$11.18 | $466,839.34 | 531.04K |
Scheduled
|
Aug 10
| ||
Form 4
| +11.09% | 48.85K |
—
|
—
| 489.28K |
Mar 26
| |||
Form 4
| +153.47% | 266.67K |
—
|
—
| 440.43K |
Jan 27
| |||
Form 4
| -4.56% | -8.31K |
$7.46 | -$61,992.60 | 173.76K |
Scheduled
|
Jan 25
| ||
Form 4
| +121.85% | 100K |
—
|
—
| 182.07K |
May 13
| |||
Form 4
|
∞
| 82.07K |
—
|
—
| 82.07K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OBALON THERAPEUTICS INC (RSLS) Snapshot price: $0.1471
InvestorDavid Moatazedi owns 5,494 units of Common Stock which is worth $808.17 and 83,619 units of Common Stock (Restricted Stock Units) which is worth $12,300.35. In the year 2017 David Moatazedi filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,422.01% | 78.13K |
—
|
—
| 83.62K |
Jul 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -50.00% | -5.49K |
$1.82 | -$9,999.08 | 5.49K |
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMERICA INC (BMRA) Snapshot price: $0.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||